Featured Research

from universities, journals, and other organizations

Policy changes urgently needed as millions of Americans to start receiving early label of Alzheimer's disease

Date:
April 7, 2014
Source:
Perelman School of Medicine at the University of Pennsylvania
Summary:
How will we, as individuals, and a society, live with brains at risk for Alzheimer's disease dementia? A neurodegenerative disease ethicist and clinician offers keen observations to help navigate ethically-charged points on the course of the disease progression. "Whether as patients or as caregivers, we all have Alzheimer's disease," says this researcher. "The question we must engage with is, How should we live with it?"

How will we, as individuals, and a society, live with brains at risk for Alzheimer's disease dementia? As part of Health Affairs' April issue, a theme issue focusing on Alzheimer's, a neurodegenerative disease ethicist and clinician with the Perelman School of Medicine at the University of Pennsylvania offers keen observations to help navigate ethically-charged points on the course of the disease progression.

Related Articles


"The new concept of Alzheimer's disease, as a spectrum of diseases ranging from people with pathological biomarkers but no symptoms, to those with advanced dementia, raises many ethical and policy-related questions for individuals and society as to how we will live with Alzheimer's disease" notes Jason Karlawish, MD, professor of Medicine, Medical Ethics and Health Policy and associate director of the Penn Memory Center. "Unlike other diseases of aging, where people learn they are at a higher risk or in the process of developing symptoms that could precipitate an acute and obvious event, such as a stroke, heart attack or hip fracture, society has not prepared or adjusted for someone to be labeled as 'likely to have Alzheimer's disease dementia' at some time in the future."

One in three seniors dies with Alzheimer's or another dementia and more than 15 million family and friends serve as caregivers to those with the disease, making Alzheimer's the most expensive condition in the United States. It affects an individual's ability to make decisions and perform daily tasks, such as taking medications safely. The progressive, untreatable illness affects not only patients, but caregivers as well. Progress in diagnostics and studies to develop prevention treatments may, in the coming years, expand the diagnosis to include persons who are asymptomatic but at risk of developing dementia caused by Alzheimer's disease.

Dr. Karlawish offers suggestions for society and individuals to adapt and prepare:

• Prepare legal, banking and financial service providers to be able to competently assess an individual's decision-making ability. Studies show that Alzheimer's patients -- even at mild and moderate stages of the disease -- often believe they are more capable at making decisions than their caregivers and physicians see. While patients may be able to express a choice, they may have impairments in their ability to understand and appreciate how an intervention could impact them.

• Caregivers of Alzheimer's patients should be offered or even prescribed to attend caregiver training, just as nutritional consultations and education are part of routine diabetes care.

• Electronic Medical Records (EMRs) should be modified to provide access to caregivers and record their roles.

• Hospice care should be aligned with goals of care for patients with advanced dementia, rather than waiting until the last 6-months of life as currently required for insurance coverage.

• Prediction models and treatment algorithms will need to be developed as "biomarker positive" people are identified to have a brain at risk before symptoms emerge.

• Legal reforms should be sought to minimize discrimination in employment and insurability as people are deemed at risk in pre-clinical stages.

"Whether as patients or as caregivers, we all have Alzheimer's disease," says Karlawish. "The question we must engage with is, How should we live with it?"


Story Source:

The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Karlawish. How Are We Going To Live With Alzheimer's Disease? Health Affairs, 2014; 33 (4): 541 DOI: 10.1377/hlthaff.2014.0089

Cite This Page:

Perelman School of Medicine at the University of Pennsylvania. "Policy changes urgently needed as millions of Americans to start receiving early label of Alzheimer's disease." ScienceDaily. ScienceDaily, 7 April 2014. <www.sciencedaily.com/releases/2014/04/140407164554.htm>.
Perelman School of Medicine at the University of Pennsylvania. (2014, April 7). Policy changes urgently needed as millions of Americans to start receiving early label of Alzheimer's disease. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/2014/04/140407164554.htm
Perelman School of Medicine at the University of Pennsylvania. "Policy changes urgently needed as millions of Americans to start receiving early label of Alzheimer's disease." ScienceDaily. www.sciencedaily.com/releases/2014/04/140407164554.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins